This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Peter Beal, PhD
Professor, Department of Chemistry at UC Davis
Speaker

Profile

Pete is Professor in the Department of Chemistry at the University of California at Davis, Director of the NIH-funded UC Davis Chemical Biology Graduate Program and Chief ADAR Scientist at ProQR. For over 25 years, work in the Beal laboratory has advanced understanding of the structures and mechanism of action for the ADAR enzymes responsible for adenosine to inosine RNA editing in humans. In addition, his group has led in the development of structure-guided methods for optimizing chemically modified oligonucleotides for recruitment of RNA-binding proteins including ADARs. Beal teaches organic chemistry at the undergraduate level and several classes in nucleic acids chemistry and chemical biology at the graduate level. He has authored over 100 peer-reviewed publications in the field of RNA chemical biology and mentored over 50 Ph.D. and M.S. degree students.

Agenda Sessions

  • The Impact of Nucleoside Analogs on the Activity of Oligonucleotides that Direct ADARs for Therapeutic RNA Editing

    10:45am
  • Advancing Axiomer ADAR RNA Editing Platform: Therapeutic Applications and Progress Towards Clinical Development

    2:00pm